Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHA:603567)
China flag China · Delayed Price · Currency is CNY
12.46
+0.47 (3.92%)
Jul 25, 2025, 3:00 PM CST

SHA:603567 Revenue

Heilongjiang ZBD Pharmaceutical had revenue of 468.94M CNY in the quarter ending March 31, 2025, a decrease of -58.03%. This brings the company's revenue in the last twelve months to 2.06B, down -31.29% year-over-year. In the year 2024, Heilongjiang ZBD Pharmaceutical had annual revenue of 2.70B, down -13.84%.

Revenue (ttm)
2.06B
Revenue Growth
-31.29%
P/S Ratio
5.69
Revenue / Employee
875.09K
Employees
2,349
Market Cap
11.70B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20242.70B-434.25M-13.84%
Dec 31, 20233.14B-1.08B-25.53%
Dec 31, 20224.21B87.33M2.12%
Dec 31, 20214.13B723.07M21.24%
Dec 31, 20203.40B111.89M3.40%
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition